impact. Let's bring in Kim Rivery of True Leave. She was at the signing this afternoon.Kim, great to have you with us. >> Thanks so much for having me. How much does this actually help your company and how much of it is symbolic.>> Well, I mean, first of all, the fact that President Trump had the first uh meaningful cannabis policy reform action since cannabis was scheduled back in the 70s. I would say it's a pretty it's a pretty monumental day. Um like you said in the intro, it does two things.It first of ...

I am pleased to announce that I will be signing an executive order to reschedule marijuana from a schedule one to a schedule 3 control substance with legitimate medical uses. For decades, this action has been requested by American patients suffering from extreme pain, incurable diseases, aggressive cancers, seizure disorders, neurological problems, and more, including numerous veterans with service related injuries, and older Americans who live with chronic medical problems that severely degrade their quali ...

Just a short time ago, President Trump announced a new change on cannabis policy. In an executive order signed this afternoon, the president laid out his intention to reclassify cannabis under the Controlled Substances Act. Right now, cannabis is a schedule one substance along with drugs like heroin, LSD.Under the law, these drugs are considered to have the highest potential for abuse and no medical use. Under the executive order, cannabis would now become a schedule three substance, falling into the same c ...

Thank you very much for the very kind introduction and yes indeed I was my last time here was in 1995 and there was something about coming down Morrison Street and walking into the building that made me want to check that my socks were pulled up and that my shirt was tucked in and I'm still feeling a little bit sort of tacky in that but but hopefully I'm okay and hopefully no one no one uh gives me Friday detention. Um so uh indeed um I'm I'm a a blood doctor. That's that's uh that's what I do.And so I see ...

Autoimmune disease rates sharply increase after age 50, with cases often unrecognized for years, according to a Mayo Clinic study https://t.co/LOtmn0BWVz ...

Core Argument - The central argument is that aging should be treated as a disease, warranting the same level of research and resources as other deadly conditions [1][2][3] - The industry aims to shift public perception, as currently only 41% of Americans believe medical treatments to slow aging would be beneficial for society [3] - The industry emphasizes the need to convince investors and politicians about the value of longevity research, given that over half of Americans may not support it [5][6] Ethical Considerations & Counterarguments - The industry addresses concerns that aging research will only benefit the wealthy by arguing that aging affects everyone, and the solution is to expand access to healthcare, not limit it [8][9] - The industry refutes the argument that a growing older population will deplete Earth's resources, citing advancements in sustainable technology and the low consumption rates of long-lived societies [10][11][12] - The industry challenges the notion that longer lifespans will bankrupt social security systems, highlighting the potential for older individuals to remain productive and contribute trillions of dollars to the GDP [13][14] - The industry addresses the concern of competing healthcare priorities by reiterating that aging is a root cause of many diseases, making it a crucial area for investment [15][16] Societal Impact - The industry argues that social structures should adapt to changing needs, as they already have, rather than hindering progress in longevity research [18][19] - The industry dismisses the idea that progress will stagnate with longer lifespans, pointing to the current rapid pace of technological change despite increasing longevity [20][21] - The industry counters the existential argument that life's meaning is tied to its finite nature, asserting that value comes from contributions and engagement, which can be amplified by a longer life [21][22][23] - The industry challenges the notion that fighting death is unnatural, comparing it to other accepted medical interventions like antibiotics and organ transplants [23][24] Call to Action - The industry advocates for expanding healthspan and lifespan research to uncover the root causes of diseases and increase the number of years people can actively contribute to society [26] - The industry urges stakeholders to advocate for aging research and increase public support from 41% to 100%, emphasizing its potential to improve the world [27]

Autoimmune disease rates sharply increase after age 50, with cases often unrecognized for years, according to a Mayo Clinic study https://t.co/5basIag9Aw ...

Foreign medical researchers are looking for places that are friendlier to them and their work than Donald Trump’s migrant-wary and science-sceptical America.One increasingly attractive destination is China https://t.co/Rg8YlYzlI8 ...

[Music] Hi everybody. My name is Dr. . McKenzie Bolan and I am a very proud neuroscientist.My credentials include a pretty cool PhD in biomedical sciences and having spent a substantial amount of time interacting with the US medical system following a head trauma. Now, that's where my curiosity in the brain really began. I got to share my experience as a long-term patient on the TED stage a few years ago, and I encourage my fellow neuron nerds in the audience to go check that out.However, today we're going ...

What causes chronic pain is often a mystery. But researchers have made a discovery that could lead to a more comfortable future for sufferers https://t.co/ioevUVtsAU ...